Atypical protein kinase C in insulin action and insulin resistance.
about
Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP).RNAi screening for kinases and phosphatases identifies FoxO regulatorsBreviscapine ameliorates cardiac dysfunction and regulates the myocardial Ca(2+)-cycling proteins in streptozotocin-induced diabetic rats.Skeletal muscle insulin resistance in endocrine disease.Prostaglandin F2alpha represses IGF-I-stimulated IRS1/phosphatidylinositol-3-kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase.The ontogeny of insulin signaling in the preterm baboon model.Insulin resistance for glucose uptake and Akt2 phosphorylation in the soleus, but not epitrochlearis, muscles of old vs. adult ratsMetabolic syndrome and insulin resistance: underlying causes and modification by exercise training.Mechanisms for increased insulin-stimulated Akt phosphorylation and glucose uptake in fast- and slow-twitch skeletal muscles of calorie-restricted ratsDifferential effects of exposure to maternal obesity or maternal weight loss during the periconceptional period in the sheep on insulin signalling molecules in skeletal muscle of the offspring at 4 months of age.Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation.Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivoUpregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance.Exercise in the metabolic syndrome.Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid lossProtein kinase Cδ differentially regulates cAMP-dependent translocation of NTCP and MRP2 to the plasma membrane.Glucose transporter 4: cycling, compartments and controversies.Role of adipose and hepatic atypical protein kinase C lambda (PKCλ) in the development of obesity and glucose intolerance.Docosahexaenoic acid (DHA) and hepatic gene transcriptionCeramide signaling in cancer and stem cells.Potential mechanisms of exercise in gestational diabetesInsulin signalling mechanisms for triacylglycerol storage.Airway PI3K pathway activation is an early and reversible event in lung cancer development.Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.The signal transduction pathway of PKC/NF-kappa B/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats.Insulin signalling in the heart.Phosphorylation and recruitment of BAF60c in chromatin remodeling for lipogenesis in response to insulin.Phosphorylation of IRS proteins, insulin action, and insulin resistance.Enforced expression of protein kinase C in skeletal muscle causes physical inactivity, fatty liver and insulin resistance in the brain.The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis.Atypical protein kinase C activity in the hypothalamus is required for lipopolysaccharide-mediated sickness responses.Improved insulin sensitivity after exercise: focus on insulin signaling.Docking proteins.Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1cThe impact of insulin resistance on the kidney and vasculature.Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway.Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinase.Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway.Effects of phenotypic residual feed intake on response to a glucose tolerance test and gene expression in the insulin signaling pathway in longissimus dorsi in beef cattle.Dynamics of insulin signalling in liver during hyperinsulinemic euglycaemic clamp conditions in vivo and the effects of high-fat feeding in male mice.
P2860
Q31813092-CDA36AC4-25E4-40F7-8940-FEFB33D6FECDQ33371685-88B7D519-93F1-4791-B544-F42CD1F15D2EQ33514446-B55EC3E3-FDCA-440C-AF40-21082081ABA8Q33734293-83DF8279-CDA4-4E4B-9353-ADD1D5B22458Q33735911-C5B0B779-9450-452B-9E27-FDAF0BA08BC6Q33848265-1D88CE4F-DF44-46B9-A95A-AD8616B6AC66Q33917344-CA638C9E-1E33-47D5-AFEE-A146DDE9B3E6Q34031701-C573C1F4-D113-4AD5-ACF7-6DDCE09697E4Q35055461-8851B97D-626B-4C89-8E5B-9E2BA18CDD83Q35080996-1EDCD4DD-781A-4325-A58C-EA993B60D286Q35131032-10A59396-3D29-49C7-AA45-95992249420AQ35720274-7EF28BC3-166E-4069-B7FD-72EB38442DBEQ35785726-CCDFA63D-C5BD-4540-9326-FF7C10D4838BQ36102382-DD99CE81-E94F-4819-9D18-4EFD3B8D4F4DQ36106076-297A5590-4083-4C11-9195-30E96857A452Q36309564-54611267-0C6F-42A9-B669-95292A22CED7Q36327829-1F74B4D5-19E2-4E06-A950-B1F9742E4C4FQ36719159-3950F7E9-E928-41B6-81BC-F01513490522Q36725271-D6802205-7026-42FE-8A10-AF583B083D05Q36803735-E6431E07-7C6F-457F-8428-0CD8648EC003Q36830035-1801E81B-4B1A-44E8-8FF8-189A0DBCFDBBQ36838847-CB2BA2A2-5241-4552-ACDC-F41DBFD21B74Q36959707-F3026586-A1E3-4C6B-99A7-274AAC4727BFQ37072669-8A019DB8-0689-4910-ADCC-1AC7C850E2DDQ37120093-81D0C926-1057-403C-8138-FA4084F0CA2DQ37129268-29C92E49-AD3E-4590-9E22-C2A5BBA3B603Q37206403-3A937BEF-4F18-4868-A7CD-B4AF9CDA32E3Q37252616-84A60546-2C73-4611-A35B-B0EE8FE0021DQ37295284-DE51EB9B-E982-48A2-82EE-BDAEC5552A66Q37333999-7CF51553-965A-4FF5-8EB6-756B41E1BB0EQ37482997-DED24C79-8148-4CA3-B40E-2CA3391BFD86Q37635741-7330FF00-DE85-4C79-B893-3BA93670FE53Q37795116-49BCCBC3-82BC-4A88-B10B-389422D80A07Q38666646-7B581BA4-0D7D-453D-9396-4646D630F271Q38982413-D5DAFD72-5B47-4611-86E0-4C6EB88CAE80Q39124878-A4BFE650-650C-4E34-8EF3-9AFA881682A9Q39880680-87AAF738-0111-49D0-913E-0BB209BDDE62Q42411093-F900B953-6194-4AED-9FB4-4A196EC3417DQ44783076-3F09FBD1-52FF-4E29-AAEF-77420AD80C31Q46833712-993D7680-9E9C-4992-B332-2FAF332FC83B
P2860
Atypical protein kinase C in insulin action and insulin resistance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Atypical protein kinase C in insulin action and insulin resistance.
@ast
Atypical protein kinase C in insulin action and insulin resistance.
@en
type
label
Atypical protein kinase C in insulin action and insulin resistance.
@ast
Atypical protein kinase C in insulin action and insulin resistance.
@en
prefLabel
Atypical protein kinase C in insulin action and insulin resistance.
@ast
Atypical protein kinase C in insulin action and insulin resistance.
@en
P2093
P356
P1476
Atypical protein kinase C in insulin action and insulin resistance.
@en
P2093
M L Standaert
R V Farese
P304
P356
10.1042/BST0330350
P577
2005-04-01T00:00:00Z